EAN News Network - Episode 8
A multiple sclerosis expert, Dr Brownlee shares study design and clinical data on relapse following discontinuation of ozanimod in patients with multiple sclerosis.
Germinal Center Activity Shows Potential As Target of Rituximab in NMOSD
Incorporating Technology and Virtual Reality in Parkinson Disease and Neurological Disorders: Jay Alberts, PhD
Potential Therapeutic Role of the Endocannabinoid System for Migraine
Differences in the Genetic Mutations of ALS: Anna Underhill, BS